GUAIFENESIN- guaifenesin tablet
APNAR PHARMA LP
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Use
Warnings
Ask doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center immediately.
Directions
Do not exceed 6 doses in a 24 hour period or as directed by a doctor
GUAIFENESIN
guaifenesin tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - APNAR PHARMA LP (079568229) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Apnar Pharma Private Limited | 876730408 | analysis(24689-122) , manufacture(24689-122) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
APNAR PHARMA LLP | 118530917 | pack(24689-122) , label(24689-122) |